BL 11778
Latest Information Update: 14 Aug 2003
At a glance
- Originator Eli Lilly and Company
- Class Antihyperglycaemics
- Mechanism of Action Insulin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 14 Aug 2003 No development reported - Preclinical for Type-2 diabetes mellitus in Germany (PO)
- 29 May 2001 Preclinical development for Type-2 diabetes mellitus in Germany (PO)